证券记录 · 已归档季度
TMDX
TransMedics Group, Inc. · Healthcare · Medical - Devices
21被追踪持有人
+2Δ持有人
20.81M持有股份
$2.34B报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +10.5% ·
股份流向 +3.4% ·
净新建仓位 +4.8%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 374 | $29,408 | n/a | −1 |
| Q2 2026 | 103 | -3 | 25.85M | $1.72B | +11 | −15 |
| Q1 2026 | 110 | -2 | 27.24M | $2.71B | +6 | −9 |
| Q4 2025 | 113 | -2 | 29.10M | $3.52B | +1 | −2 |
| Q3 2025 | 21 | +2 | 20.81M | $2.34B | +2 | −1 |
| Q2 2025 | 17 | +3 | 18.14M | $2.43B | +3 | n/a |
| Q1 2025 | 11 | -1 | 3.86M | $259.47M | +2 | −3 |
| Q4 2024 | 12 | +2 | 3.62M | $225.65M | +3 | −1 |
| Q3 2024 | 9 | -4 | 2.19M | $344.12M | n/a | −4 |
| Q2 2024 | 13 | n/a | 2.46M | $370.15M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 5.33M | +2.1% | $598.21M | 0.0% | ▲ Add | 2 | SEC ↗ ×16 |
| 2 | Fidelity (FMR) ✦ | 5.06M | +0.8% | $568.22M | 0.0% | ▲ Add | 2 | SEC ↗ ×7 |
| 3 | The Vanguard Group ✦ (被动) | 3.61M | +0.3% | $404.55M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 4 | State Street Global Advisors ✦ (被动) | 1.28M | -0.7% | $143.56M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 5 | Geode Capital Management ✦ (被动) | 813.57K | +1.1% | $91.30M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | JPMorgan Chase ✦ | 784.71K | n/a | $88.04M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 7 | Goldman Sachs Group ✦ | 703.58K | n/a | $78.94M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 8 | Two Sigma Investments ✦ | 635.39K | +54.2% | $71.29M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 9 | Morgan Stanley ✦ | 547.82K | n/a | $61.47M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 10 | Marshall Wace ✦ | 541.68K | -0.9% | $60.78M | 0.1% | ▼ Trim | 3 | SEC ↗ ×3 |
| 11 | T. Rowe Price ✦ | 398.16K | +188.8% | $44.67M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 12 | Baillie Gifford ✦ | 260.72K | -0.8% | $29.25M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 13 | Capital World Investors ✦ | 227.44K | 0.0% | $25.52M | 0.0% | Held | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 216.14K | -2.2% | $24.25M | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 15 | Renaissance Technologies ✦ | 145.20K | 新增 | $16.29M | 0.0% | New | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 124.92K | -20.1% | $14.02M | 0.0% | ▼ Trim | 4 | SEC ↗ ×3 |
| 17 | Millennium Management ✦ | 48.81K | -57.5% | $5.48M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 37.27K | -51.6% | $4.18M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 30.09K | 新增 | $3.38M | 0.0% | New | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 8.60K | +73.0% | $964,583 | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 21 | Gotham Asset Management ✦ | 8.24K | +160.8% | $924,191 | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Renaissance Technologies | $16.29M | 0.0% |
| Bridgewater Associates | $3.38M | 0.0% |
已清仓
| Norges Bank | $5.40M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 412 持有人, 36.17M 股份, $3.51B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据